REGENERON PHARMACEUTICALS, INC. Reports Q1 2026 Financial Results
2026-04-29SEC Filing 10-Q (0000872589-26-000016)
Please check the link below for details.
Ticker mentioned:REGN
Source:Original SEC Document β
Please check the link below for details.